Pharmacy assistance programs in a community health center setting

Area of Science:

• Health Economics
• Pharmaceutical Access
• Community Health

Background:

• Rising healthcare costs are significantly driven by escalating prescription drug expenses.
• Community health centers (CHCs) often serve underserved populations with limited pharmaceutical access.
• Patient assistance programs (PAPs) sponsored by pharmaceutical companies offer a potential solution.

Purpose of the Study:

• To evaluate the role and impact of pharmaceutical patient assistance programs in community health centers.
• To assess the cost-saving potential and benefits of systematically utilizing PAPs for indigent patient populations.

Main Methods:

• Case study analysis of La Casa de Buena Salud, a rural CHC in New Mexico.
• Examination of the systematic implementation and utilization of pharmaceutical company-sponsored PAPs.
• Assessment of cost savings and access improvements for indigent patients.

Main Results:

• La Casa de Buena Salud successfully provided substantial pharmaceutical access to indigent patients via PAPs.
• Efficient organization and systematic employment of PAPs yield considerable cost savings for CHCs and patients.
• Secondary benefits extend to the broader medical community.

Conclusions:

• Pharmaceutical PAPs are a viable strategy for CHCs to enhance medication access for vulnerable populations.
• Systematic and efficient program implementation is key to maximizing cost savings and benefits.
• A comprehensive national approach may be necessary to fully leverage PAPs across all CHCs.